2-[5-(3-{2-[(2,4-dichloroanilinocarbonyl)oxy]ethyl}-4methoxyphenyl)-3-phenyl]acetic acid | 478373-15-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-[5-(3-{2-[(2,4-dichloroanilinocarbonyl)oxy]ethyl}-4methoxyphenyl)-3-phenyl]acetic acid
• 英文别名: 3-(3-{2-[(2,4-dichloroanilinocarbonyl)oxy]ethyl}-4methoxyphenyl)phenylacetic acid；2-[3-[3-[2-[(2,4-Dichlorophenyl)carbamoyloxy]ethyl]-4-methoxyphenyl]phenyl]acetic acid
• CAS: 478373-15-8
• 化学式: C₂₄H₂₁Cl₂NO₅
• 分子量: 474.34
• InChiKey: YHZQSFAVDDLIAY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  32
• 可旋转键数：
  9
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  84.9
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  2,4-二氯苯基异氰酸酯 生成 2-[5-(3-{2-[(2,4-dichloroanilinocarbonyl)oxy]ethyl}-4methoxyphenyl)-3-phenyl]acetic acid
  参考文献：
  名称：

  EP1394147

  摘要：

  公开号：

文献信息

• Carboxylic acid derivative and medicine comprising salt or ester of the same
  申请人：——

  公开号：US20040214888A1

  公开（公告）日：2004-10-28

  The present invention provides novel carboxylic acid derivatives useful as an insulin sensitizer, a salt thereof or a hydrate of them, and a medicament comprising the derivative as the active ingredient. Specifically, it provides a carboxylic acid derivative represented by the following formula: 1 (wherein L represents a single bond, or a C1 to C6 alkylene group, a C2 to C6 alkenylene group or a C2 to C6 alkynylene group, each of which may have one or more substituent groups; M represents a single bond, or a C1 to C6 alkylene group, a C2 to C6 alkenylene group or a C2 to C6 alkynylene group, each of which may have one or more substituent groups; T represents a single bond, or a C1 to C3 alkylene group, a C2 to C3 alkenylene group or a C2 to C3 alkynylene group, each of which may have one or more substituent groups; W represents a carboxyl group; X represents a single bond, an oxygen atom, or a group represented by the various substituent groups including —NR X1 CQ 1 O— (wherein Q 1 represents an oxygen atom or a sulfur atom; R X1 represents a hydrogen atom, a cyano group, a formyl group, or various groups including a C1 to C6 alkyl group and a C1 to C6 hydroxyalkyl group, each of which may have one or more substituent groups), ONR X1 CQ 1 —, —NR X1 CQ 1 —, —CQ 1 NR X1 —, —NR X1a CQ 1 NR X1b —, —Q 2 SO 2 — and —SO 2 Q 2 —; Y represents a 5 to 14-membered aromatic group which may have one or more substituent groups and one or more hetero atoms, or a C3 to C7 alicyclic hydrocarbon group; and the rings Z and U may be the same as or different from each other and each represents a 5 to 14-membered aromatic group which may have 1 to 4 substituent groups and one or more hetero atoms, and the ring may be partially saturated.), a salt thereof, an ester thereof or a hydrate of them.

  本发明提供了一种新型羧酸衍生物，可用作胰岛素增敏剂，其盐或其水合物，以及包含该衍生物作为活性成分的药物。具体而言，本发明提供了一种由以下式子表示的羧酸衍生物：1（其中L表示单键，或C1至C6烷基，C2至C6烯基或C2至C6炔基，每个基团都可以有一个或多个取代基；M表示单键，或C1至C6烷基，C2至C6烯基或C2至C6炔基，每个基团都可以有一个或多个取代基；T表示单键，或C1至C3烷基，C2至C3烯基或C2至C3炔基，每个基团都可以有一个或多个取代基；W表示羧基；X表示单键，氧原子，或由各种取代基表示的基团，包括-NRX1CQ1O-（其中Q1表示氧原子或硫原子；RX1表示氢原子，氰基，甲酰基或各种基团，包括C1至C6烷基和C1至C6羟基烷基，每个基团都可以有一个或多个取代基），ONRX1CQ1-，-NRX1CQ1-，-CQ1NRX1-，-NRX1aCQ1NRX1b-，-Q2SO2-和-SO2Q2-；Y表示一个具有1个或多个取代基和1个或多个杂原子的5至14环芳基，或一个C3至C7脂环烃基；环Z和环U可以相同或不同，每个环表示一个具有1至4个取代基和1个或多个杂原子的5至14环芳基，环可能部分饱和），其盐，酯或其水合物。
• CARBOXYLIC ACID DERIVATIVE AND MEDICINE COMPRISING SALT OR ESTER OF THE SAME
  申请人：Eisai Co., Ltd.

  公开号：EP1394147A1

  公开（公告）日：2004-03-03

  The present invention provides novel carboxylic acid derivatives useful as an insulin sensitizer, a salt thereof or a hydrate of them, and a medicament comprising the derivative as the active ingredient. Specifically, it provides a carboxylic acid derivative represented by the following formula: (wherein L represents a single bond, or a C1 to C6 alkylene group, a C2 to C6 alkenylene group or a C2 to C6 alkynylene group, each of which may have one or more substituent groups; M represents a single bond, or a C1 to C6 alkylene group, a C2 to C6 alkenylene group or a C2 to C6 alkynylene group, each of which may have one or more substituent groups; T represents a single bond, or a C1 to C3 alkylene group, a C2 to C3 alkenylene group or a C2 to C3 alkynylene group, each of which may have one or more substituent groups; W represents a carboxyl group; X represents a single bond, an oxygen atom, or a group represented by the various substituent groups including -NRX1CQ1O- (wherein Q1 represents an oxygen atom or a sulfur atom; RX1 represents a hydrogen atom, a cyano group, a formyl group, or various groups including a C1 to C6 alkyl group and a C1 to C6 hydroxyalkyl group, each of which may have one or more substituent groups) , ONRX1CQ1-, -NRX1CQ1-, -CQ1NRX1-, -NRX1aCQ1NRX1b-, -Q2SO2- and -SO2Q2-; Y represents a 5 to 14-membered aromatic group which may have one or more substituent groups and one or more hetero atoms, or a C3 to C7 alicyclic hydrocarbon group; and the rings Z and U may be the same as or different from each other and each represents a 5 to 14-membered aromatic group which may have 1 to 4 substituent groups and one or more hetero atoms, and the ring may be partially saturated.), a salt thereof, an ester thereof or a hydrate of them.

  本发明提供了可用作胰岛素增敏剂的新型羧酸衍生物、其盐或水合物，以及以该衍生物为活性成分的药物。具体地说，它提供了由下式表示的羧酸衍生物： (其中 L 代表单键，或 C1 至 C6 亚烷基、C2 至 C6 烯基或 C2 至 C6 亚炔基，其中每个基团可具有一个或多个取代基；M 代表单键，或 C1 至 C6 亚烷基、C2 至 C6 烯基或 C2 至 C6 亚炔基，其中每个基团可具有一个或多个取代基；T 代表单键，或 C1 至 C3 亚烷基、C2 至 C3 烯基或 C2 至 C3 亚炔基，其中每个基团可带有一个或多个取代基； W 代表羧基； X 代表单键、氧原子或由各种取代基团代表的基团，包括 -NRX1CQ1O- （其中 Q1 代表氧原子或硫原子；RX1 代表氢原子、氰基、甲酰基或包括 C1 至 C6 烷基和 C1 至 C6 羟烷基在内的各种基团，其中每个基团可具有一个或多个取代基）、 ONRX1CQ1-、-NRX1CQ1-、-CQ1NRX1-、-NRX1aCQ1NRX1b-、-Q2SO2- 和 -SO2Q2-；Y 代表 5 至 14 元芳香基团，可带有一个或多个取代基团和一个或多个杂原子，或 C3 至 C7 脂环烃基团；且环 Z 和 U 可彼此相同或不同，且各自代表 5 至 14 元芳香基团，可带有 1 至 4 个取代基团和一个或多个杂原子，且环可为部分饱和。)、其盐、其酯或它们的水合物。
• US7687664B2
  申请人：——

  公开号：US7687664B2

  公开（公告）日：2010-03-30
• EP1394147
  申请人：——

  公开号：——

  公开（公告）日：——